These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 12501222

  • 1. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
    Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW, Chung SC, Sung JJ.
    N Engl J Med; 2002 Dec 26; 347(26):2104-10. PubMed ID: 12501222
    [Abstract] [Full Text] [Related]

  • 2. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 26; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 3. Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
    Lanas A.
    N Engl J Med; 2003 Jun 12; 348(24):2464-6; author reply 2464-6. PubMed ID: 12802035
    [No Abstract] [Full Text] [Related]

  • 4. NSAIDs, Helicobacter pylori, and Pandora's Box.
    Graham DY.
    N Engl J Med; 2002 Dec 26; 347(26):2162-4. PubMed ID: 12501230
    [No Abstract] [Full Text] [Related]

  • 5. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
    Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VK, Wu JC, Lau JY, Hui Y, Lai MS, Chan HL, Sung JJ.
    N Engl J Med; 2001 Mar 29; 344(13):967-73. PubMed ID: 11274623
    [Abstract] [Full Text] [Related]

  • 6. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.
    Chan FK, Wong VW, Suen BY, Wu JC, Ching JY, Hung LC, Hui AJ, Leung VK, Lee VW, Lai LH, Wong GL, Chow DK, To KF, Leung WK, Chiu PW, Lee YT, Lau JY, Chan HL, Ng EK, Sung JJ.
    Lancet; 2007 May 12; 369(9573):1621-6. PubMed ID: 17499604
    [Abstract] [Full Text] [Related]

  • 7. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 12; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
    Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL.
    Lancet; 2010 Jul 17; 376(9736):173-9. PubMed ID: 20638563
    [Abstract] [Full Text] [Related]

  • 9. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.
    Chan FK, Ching JY, Hung LC, Wong VW, Leung VK, Kung NN, Hui AJ, Wu JC, Leung WK, Lee VW, Lee KK, Lee YT, Lau JY, To KF, Chan HL, Chung SC, Sung JJ.
    N Engl J Med; 2005 Jan 20; 352(3):238-44. PubMed ID: 15659723
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial.
    Kellner HL, Li C, Essex MN.
    Curr Med Res Opin; 2012 Sep 20; 28(9):1537-45. PubMed ID: 22852870
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.
    Chan FK, Hung LC, Suen BY, Wong VW, Hui AJ, Wu JC, Leung WK, Lee YT, To KF, Chung SC, Sung JJ.
    Gastroenterology; 2004 Oct 20; 127(4):1038-43. PubMed ID: 15480981
    [Abstract] [Full Text] [Related]

  • 12. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
    Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B, Godio L, Patterson S, Rodriguez-Bigas MA, Jester SL, King KL, Schumacher M, Abbruzzese J, DuBois RN, Hittelman WN, Zimmerman S, Sherman JW, Kelloff G.
    N Engl J Med; 2000 Jun 29; 342(26):1946-52. PubMed ID: 10874062
    [Abstract] [Full Text] [Related]

  • 13. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G, SUCCESS-I Investigators.
    Am J Med; 2006 Mar 29; 119(3):255-66. PubMed ID: 16490472
    [Abstract] [Full Text] [Related]

  • 14. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL, Cryer B, Amer F, Hunt B.
    Clin Gastroenterol Hepatol; 2007 Oct 29; 5(10):1167-74. PubMed ID: 17916545
    [Abstract] [Full Text] [Related]

  • 15. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor.
    Goldstein JL, Silverstein FE, Agrawal NM, Hubbard RC, Kaiser J, Maurath CJ, Verburg KM, Geis GS.
    Am J Gastroenterol; 2000 Jul 29; 95(7):1681-90. PubMed ID: 10925968
    [Abstract] [Full Text] [Related]

  • 16. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS.
    Am J Gastroenterol; 2001 Apr 29; 96(4):1019-27. PubMed ID: 11316141
    [Abstract] [Full Text] [Related]

  • 17. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S, Ittel TH, Wietholtz H.
    Z Gastroenterol; 2003 Aug 29; 41(8):719-28. PubMed ID: 12910426
    [Abstract] [Full Text] [Related]

  • 18. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
    Hawkey CJ, Karrasch JA, Szczepañski L, Walker DG, Barkun A, Swannell AJ, Yeomans ND.
    N Engl J Med; 1998 Mar 12; 338(11):727-34. PubMed ID: 9494149
    [Abstract] [Full Text] [Related]

  • 19. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.
    Chan FKL, Ching JYL, Tse YK, Lam K, Wong GLH, Ng SC, Lee V, Au KWL, Cheong PK, Suen BY, Chan H, Kee KM, Lo A, Wong VWS, Wu JCY, Kyaw MH.
    Lancet; 2017 Jun 17; 389(10087):2375-2382. PubMed ID: 28410791
    [Abstract] [Full Text] [Related]

  • 20. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS.
    JAMA; 2000 Sep 13; 284(10):1247-55. PubMed ID: 10979111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.